[Open innovation for pharmaceutical industries].

Suppr

超能文献

作者信息

Matsumoto Yayoi, Sakata Tsuneaki

出版信息

Nihon Yakurigaku Zasshi. 2013 Apr;141(4):199-204. doi: 10.1254/fpj.141.199.

DOI:10.1254/fpj.141.199

PMID:23575425

Abstract

摘要

相似文献

[Open innovation for pharmaceutical industries].

Nihon Yakurigaku Zasshi. 2013 Apr;141(4):199-204. doi: 10.1254/fpj.141.199.

Open innovation and intellectual property: time for a reboot?

Drug Discov Today. 2013 Oct;18(19-20):907-9. doi: 10.1016/j.drudis.2013.08.008. Epub 2013 Aug 16.

[Open innovation for Japanese pharmaceutical companies].

Nihon Yakurigaku Zasshi. 2013 Oct;142(4):184-9. doi: 10.1254/fpj.142.184.

[Open innovation and licensing in the pharmaceutical industry].

Nihon Yakurigaku Zasshi. 2013 Jul;142(1):28-31. doi: 10.1254/fpj.142.28.

[Open innovation: public-private partnerships in pharmaceutical R&D].

Nihon Yakurigaku Zasshi. 2013 Jul;142(1):32-8. doi: 10.1254/fpj.142.32.

Can open-source drug R&D repower pharmaceutical innovation?

Clin Pharmacol Ther. 2010 May;87(5):534-6. doi: 10.1038/clpt.2010.26.

Reinventing bioinnovation.

Clin Pharmacol Ther. 2013 Sep;94(3):279-83. doi: 10.1038/clpt.2013.129.

Deconstructing the drug development process: the new face of innovation.

Clin Pharmacol Ther. 2010 Mar;87(3):356-61. doi: 10.1038/clpt.2009.293. Epub 2010 Feb 3.

Open partnering of integrated drug discovery: continuing evolution of the pharmaceutical model.

Drug Discov Today. 2011 Apr;16(7-8):281-3. doi: 10.1016/j.drudis.2011.02.007. Epub 2011 Feb 15.

[Strategic construction of an innovative drug development pipeline by industry-academia cooperation - consortium for drug innovation in the Tokai region of Japan].

Nihon Yakurigaku Zasshi. 2014 May;143(5):254-9. doi: 10.1254/fpj.143.254.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Open innovation for pharmaceutical industries].

Nihon Yakurigaku Zasshi. 2013 Apr;141(4):199-204. doi: 10.1254/fpj.141.199.

Open innovation and intellectual property: time for a reboot?

Drug Discov Today. 2013 Oct;18(19-20):907-9. doi: 10.1016/j.drudis.2013.08.008. Epub 2013 Aug 16.

[Open innovation for Japanese pharmaceutical companies].

Nihon Yakurigaku Zasshi. 2013 Oct;142(4):184-9. doi: 10.1254/fpj.142.184.

[Open innovation and licensing in the pharmaceutical industry].

Nihon Yakurigaku Zasshi. 2013 Jul;142(1):28-31. doi: 10.1254/fpj.142.28.

[Open innovation: public-private partnerships in pharmaceutical R&D].

Nihon Yakurigaku Zasshi. 2013 Jul;142(1):32-8. doi: 10.1254/fpj.142.32.

Can open-source drug R&D repower pharmaceutical innovation?

Clin Pharmacol Ther. 2010 May;87(5):534-6. doi: 10.1038/clpt.2010.26.

Reinventing bioinnovation.

Clin Pharmacol Ther. 2013 Sep;94(3):279-83. doi: 10.1038/clpt.2013.129.

Deconstructing the drug development process: the new face of innovation.

Clin Pharmacol Ther. 2010 Mar;87(3):356-61. doi: 10.1038/clpt.2009.293. Epub 2010 Feb 3.

Open partnering of integrated drug discovery: continuing evolution of the pharmaceutical model.

Drug Discov Today. 2011 Apr;16(7-8):281-3. doi: 10.1016/j.drudis.2011.02.007. Epub 2011 Feb 15.

[Strategic construction of an innovative drug development pipeline by industry-academia cooperation - consortium for drug innovation in the Tokai region of Japan].

Nihon Yakurigaku Zasshi. 2014 May;143(5):254-9. doi: 10.1254/fpj.143.254.